A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck - Concepedia

Concepedia

Publication | Open Access

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

DOI Full Paper Access

113

Citations

30

References

2012

Year

Jonas A. de Souza, Darren W. Davis, Yujian Zhang, Arun Khattri, Tanguy Y. Seiwert, Serdal Aktolga, Stuart J. Wong, Mark Kozloff, Sreenivasa Nattam, Mark W. Lingen,

Clinical Cancer Research

Abstract

Lapatinib as a single agent in recurrent/metastatic SCCHN, although well tolerated, appears to be inactive in either EGFR inhibitor naive or refractory subjects.

References

	Year	Citations

Page 1